This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: British Columbia Cancer Agency Branch. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Silvia Thoene
Introduction
Silvia Thoene is a prominent inventor based in Vancouver, Canada. She has made significant strides in the field of cancer research through her innovative work on epigenetic defects. Her contributions are vital in understanding and potentially treating various disease states, particularly cancer.
Latest Patents
Silvia Thoene holds a patent for her groundbreaking invention titled "Reprogramming effector protein interactions to correct epigenetic defects in cancer." This patent outlines methods for reprogramming epigenetic mark readers or erasers to recognize epigenetic marks other than their natural counterparts. The reprogramming can counteract the effects of aberrant writer activity, which can lead to disease states such as cancer. The patent also discusses the use of identified reprogramming compounds in treating these conditions.
Career Highlights
Silvia is affiliated with the British Columbia Cancer Agency Branch, where she applies her expertise to advance cancer research. Her work is characterized by a commitment to developing innovative solutions that address complex biological challenges.
Collaborations
Silvia collaborates with esteemed colleagues, including Oleksandr Yakovenko and Pierre Yulmin Cheung. These partnerships enhance her research efforts and contribute to the advancement of knowledge in the field.
Conclusion
Silvia Thoene's innovative work in reprogramming epigenetic interactions represents a significant advancement in cancer research. Her contributions are paving the way for new therapeutic approaches to combat cancer and improve patient outcomes.